-
1
-
-
62649139025
-
Immunological and inflammatory functions of the interleukin-1 family
-
Dinarello CA. Immunological and inflammatory functions of the interleukin-1 family. Annu Rev Immunol 2009;27:519-50.
-
(2009)
Annu Rev Immunol
, vol.27
, pp. 519-550
-
-
Dinarello, C.A.1
-
2
-
-
0028861236
-
Inhibition of the production and effects of interleukin-1 and tumor necrosis factor α in rheumatoid arthritis [review]
-
Arend WP, Dayer JM. Inhibition of the production and effects of interleukin-1 and tumor necrosis factor α in rheumatoid arthritis [review]. Arthritis Rheum 1995;38:151-60.
-
(1995)
Arthritis Rheum
, vol.38
, pp. 151-160
-
-
Arend, W.P.1
Dayer, J.M.2
-
3
-
-
0035932519
-
Cytokine pathways and joint inflammation in rheumatoid arthritis
-
Choy EH, Panayi GS. Cytokine pathways and joint inflammation in rheumatoid arthritis. N Engl J Med 2001;344:907-16.
-
(2001)
N Engl J Med
, vol.344
, pp. 907-916
-
-
Choy, E.H.1
Panayi, G.S.2
-
4
-
-
9144261181
-
Single and combined inhibition of tumor necrosis factor, interleukin-1, and RANKL pathways in tumor necrosis factor-induced arthritis: Effects on synovial inflammation, bone erosion, and cartilage destruction
-
Zwerina J, Hayer S, Tohidast-Akrad M, Bergmeister H, Redlich K, Feige U, et al. Single and combined inhibition of tumor necrosis factor, interleukin-1, and RANKL pathways in tumor necrosis factor-induced arthritis: effects on synovial inflammation, bone erosion, and cartilage destruction. Arthritis Rheum 2004;50: 277-90.
-
(2004)
Arthritis Rheum
, vol.50
, pp. 277-290
-
-
Zwerina, J.1
Hayer, S.2
Tohidast-Akrad, M.3
Bergmeister, H.4
Redlich, K.5
Feige, U.6
-
5
-
-
0034677123
-
Development of chronic inflammatory arthropathy resembling rheumatoid arthritis in interleukin 1 receptor antagonist-deficient mice
-
Horai R, Saijo S, Tanioka H, Nakae S, Sudo K, Okahara A, et al. Development of chronic inflammatory arthropathy resembling rheumatoid arthritis in interleukin 1 receptor antagonist-deficient mice. J Exp Med 2000;191:313-20.
-
(2000)
J Exp Med
, vol.191
, pp. 313-320
-
-
Horai, R.1
Saijo, S.2
Tanioka, H.3
Nakae, S.4
Sudo, K.5
Okahara, A.6
-
6
-
-
85047693264
-
TNF-α is crucial for the development of autoimmune arthritis in IL-1 receptor antagonist-deficient mice
-
Horai R, Nakajima A, Habiro K, Kotani M, Nakae S, Matsuki T, et al. TNF-α is crucial for the development of autoimmune arthritis in IL-1 receptor antagonist-deficient mice. J Clin Invest 2004;114:1603-11.
-
(2004)
J Clin Invest
, vol.114
, pp. 1603-1611
-
-
Horai, R.1
Nakajima, A.2
Habiro, K.3
Kotani, M.4
Nakae, S.5
Matsuki, T.6
-
7
-
-
55849150906
-
Interleukin-1 drives pathogenic Th17 cells during spontaneous arthritis in interleukin-1 receptor antagonist-deficient mice
-
Koenders MI, Devesa I, Marijnissen RJ, Abdollahi-Roodsaz S, Boots AM, Walgreen B, et al. Interleukin-1 drives pathogenic Th17 cells during spontaneous arthritis in interleukin-1 receptor antagonist-deficient mice. Arthritis Rheum 2008;58:3461-70.
-
(2008)
Arthritis Rheum
, vol.58
, pp. 3461-3470
-
-
Koenders, M.I.1
Devesa, I.2
Marijnissen, R.J.3
Abdollahi-Roodsaz, S.4
Boots, A.M.5
Walgreen, B.6
-
8
-
-
0038623916
-
IL-17 production from activated T cells is required for the spontaneous development of destructive arthritis in mice deficient in IL-1 receptor antagonist
-
Nakae S, Saijo S, Horai R, Sudo K, Mori S, Iwakura Y. IL-17 production from activated T cells is required for the spontaneous development of destructive arthritis in mice deficient in IL-1 receptor antagonist. Proc Natl Acad Sci U S A 2003;100:5986-90.
-
(2003)
Proc Natl Acad Sci U S A
, vol.100
, pp. 5986-5990
-
-
Nakae, S.1
Saijo, S.2
Horai, R.3
Sudo, K.4
Mori, S.5
Iwakura, Y.6
-
9
-
-
69349093225
-
Interleukin-17 and type 17 helper T cells
-
Miossec P, Korn T, Kuchroo VK. Interleukin-17 and type 17 helper T cells. N Engl J Med 2009;361:888-98.
-
(2009)
N Engl J Med
, vol.361
, pp. 888-898
-
-
Miossec, P.1
Korn, T.2
Kuchroo, V.K.3
-
10
-
-
1042267236
-
Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion
-
Lubberts E, Koenders MI, Oppers-Walgreen B, van den Bersselaar L, Coenen-de Roo CJ, Joosten LA, et al. Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion. Arthritis Rheum 2004;50:650-9.
-
(2004)
Arthritis Rheum
, vol.50
, pp. 650-659
-
-
Lubberts, E.1
Koenders, M.I.2
Oppers-Walgreen, B.3
van den Bersselaar, L.4
Coenen-de Roo, C.J.5
Joosten, L.A.6
-
11
-
-
0037371262
-
IL-17 promotes bone erosion in murine collagen-induced arthritis through loss of the receptor activator of NF-κB ligand/osteoprotegerin balance
-
Lubberts E, van den Bersselaar L, Oppers-Walgreen B, Schwarzenberger P, Coenen-de Roo CJ, Kolls JK, et al. IL-17 promotes bone erosion in murine collagen-induced arthritis through loss of the receptor activator of NF-κB ligand/osteoprotegerin balance. J Immunol 2003;170:2655-62.
-
(2003)
J Immunol
, vol.170
, pp. 2655-2662
-
-
Lubberts, E.1
van den Bersselaar, L.2
Oppers-Walgreen, B.3
Schwarzenberger, P.4
Coenen-de Roo, C.J.5
Kolls, J.K.6
-
12
-
-
33745873727
-
A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis
-
Sutton C, Brereton C, Keogh B, Mills KH, Lavelle EC. A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis. J Exp Med 2006;203:1685-91.
-
(2006)
J Exp Med
, vol.203
, pp. 1685-1691
-
-
Sutton, C.1
Brereton, C.2
Keogh, B.3
Mills, K.H.4
Lavelle, E.C.5
-
13
-
-
58149268052
-
Induction, function and regulation of IL-17-producing T cells
-
Mills KH. Induction, function and regulation of IL-17-producing T cells. Eur J Immunol 2008;38:2636-49.
-
(2008)
Eur J Immunol
, vol.38
, pp. 2636-2649
-
-
Mills, K.H.1
-
14
-
-
64049089798
-
Critical regulation of early Th17 cell differentiation by interleukin-1 signaling
-
Chung Y, Chang SH, Martinez GJ, Yang XO, Nurieva R, Kang HS, et al. Critical regulation of early Th17 cell differentiation by interleukin-1 signaling. Immunity 2009;30:576-87.
-
(2009)
Immunity
, vol.30
, pp. 576-587
-
-
Chung, Y.1
Chang, S.H.2
Martinez, G.J.3
Yang, X.O.4
Nurieva, R.5
Kang, H.S.6
-
15
-
-
0029875804
-
Anticytokine treatment of established type II collagen-induced arthritis in DBA/1 mice: A comparative study using anti-TNFα, anti-IL-1α/β, and IL-1Ra
-
Joosten LA, Helsen MM, van de Loo FA, van den Berg WB. Anticytokine treatment of established type II collagen-induced arthritis in DBA/1 mice: a comparative study using anti-TNFα, anti-IL-1α/β, and IL-1Ra. Arthritis Rheum 1996;39:797-809.
-
(1996)
Arthritis Rheum
, vol.39
, pp. 797-809
-
-
Joosten, L.A.1
Helsen, M.M.2
van de Loo, F.A.3
van den Berg, W.B.4
-
16
-
-
0032752705
-
IL-1α/β blockade prevents cartilage and bone destruction in murine type II collagen-induced arthritis, whereas TNF-α blockade only ameliorates joint inflammation
-
Joosten LA, Helsen MM, Saxne T, van de Loo FA, Heinegard D, van den Berg WB. IL-1α/β blockade prevents cartilage and bone destruction in murine type II collagen-induced arthritis, whereas TNF-α blockade only ameliorates joint inflammation. J Immunol 1999;163:5049-55.
-
(1999)
J Immunol
, vol.163
, pp. 5049-5055
-
-
Joosten, L.A.1
Helsen, M.M.2
Saxne, T.3
van de Loo, F.A.4
Heinegard, D.5
van den Berg, W.B.6
-
17
-
-
0029971948
-
IL-1β converting enzyme inhibition blocks progression of type II collagen induced arthritis in mice
-
Ku G, Faust T, Lauffer LL, Livingston DJ, Harding MW. IL-1β converting enzyme inhibition blocks progression of type II collagen induced arthritis in mice. Cytokine 1996;8:377-86.
-
(1996)
Cytokine
, vol.8
, pp. 377-386
-
-
Ku, G.1
Faust, T.2
Lauffer, L.L.3
Livingston, D.J.4
Harding, M.W.5
-
18
-
-
0036166344
-
Suppression of autoimmune arthritis in interleukin-1-deficient mice in which T cell activation is impaired due to low levels of CD40 ligand and OX40 expression on T cells
-
Saijo S, Asano M, Horai R, Yamamoto H, Iwakura Y. Suppression of autoimmune arthritis in interleukin-1-deficient mice in which T cell activation is impaired due to low levels of CD40 ligand and OX40 expression on T cells. Arthritis Rheum 2002;46:533-44.
-
(2002)
Arthritis Rheum
, vol.46
, pp. 533-544
-
-
Saijo, S.1
Asano, M.2
Horai, R.3
Yamamoto, H.4
Iwakura, Y.5
-
19
-
-
75749090445
-
Enhanced Th1 and Th17 responses and arthritis severity in mice with a deficiency of myeloid cell-specific interleukin-1 receptor antagonist
-
Lamacchia C, Palmer G, Seemayer CA, Talabot-Ayer D, Gabay C. Enhanced Th1 and Th17 responses and arthritis severity in mice with a deficiency of myeloid cell-specific interleukin-1 receptor antagonist. Arthritis Rheum. 2009:62:452-62.
-
(2009)
Arthritis Rheum
, vol.62
, pp. 452-462
-
-
Lamacchia, C.1
Palmer, G.2
Seemayer, C.A.3
Talabot-Ayer, D.4
Gabay, C.5
-
20
-
-
0031156936
-
Accelerated collagen-induced arthritis in IFN-γ receptor-deficient mice
-
Vermeire K, Heremans H, Vandeputte M, Huang S, Billiau A, Matthys P. Accelerated collagen-induced arthritis in IFN-γ receptor-deficient mice. J Immunol 1997;158:5507-13.
-
(1997)
J Immunol
, vol.158
, pp. 5507-5513
-
-
Vermeire, K.1
Heremans, H.2
Vandeputte, M.3
Huang, S.4
Billiau, A.5
Matthys, P.6
-
21
-
-
0031572430
-
Dual role of IL-12 in early and late stages of murine collagen type II arthritis
-
Joosten LA, Lubberts E, Helsen MM, van den Berg WB. Dual role of IL-12 in early and late stages of murine collagen type II arthritis. J Immunol 1997;159:4094-102.
-
(1997)
J Immunol
, vol.159
, pp. 4094-4102
-
-
Joosten, L.A.1
Lubberts, E.2
Helsen, M.M.3
van den Berg, W.B.4
-
22
-
-
0034268386
-
Interleukin-18, a proinflammatory cytokine
-
Dinarello CA. Interleukin-18, a proinflammatory cytokine. Eur Cytokine Netw 2000;11:483-6.
-
(2000)
Eur Cytokine Netw
, vol.11
, pp. 483-486
-
-
Dinarello, C.A.1
-
23
-
-
58149251898
-
Late developmental plasticity in the T helper 17 lineage
-
Lee YK, Turner H, Maynard CL, Oliver JR, Chen D, Elson CO, et al. Late developmental plasticity in the T helper 17 lineage. Immunity 2009;30:92-107.
-
(2009)
Immunity
, vol.30
, pp. 92-107
-
-
Lee, Y.K.1
Turner, H.2
Maynard, C.L.3
Oliver, J.R.4
Chen, D.5
Elson, C.O.6
-
24
-
-
66649121678
-
An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist
-
Aksentijevich I, Masters SL, Ferguson PJ, Dancey P, Frenkel J, van Royen-Kerkhoff A, et al. An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist. N Engl J Med 2009;360:2426-37.
-
(2009)
N Engl J Med
, vol.360
, pp. 2426-2437
-
-
Aksentijevich, I.1
Masters, S.L.2
Ferguson, P.J.3
Dancey, P.4
Frenkel, J.5
van Royen-Kerkhoff, A.6
-
25
-
-
46149100545
-
The human anti-IL-1β monoclonal antibody ACZ885 is effective in joint inflammation models in mice and in a proof-of-concept study in patients with rheumatoid arthritis
-
Alten R, Gram H, Joosten LA, van den Berg WB, Sieper J, Wassenberg S, et al. The human anti-IL-1β monoclonal antibody ACZ885 is effective in joint inflammation models in mice and in a proof-of-concept study in patients with rheumatoid arthritis. Arthritis Res Ther 2008;10:R67.
-
(2008)
Arthritis Res Ther
, vol.10
-
-
Alten, R.1
Gram, H.2
Joosten, L.A.3
van den Berg, W.B.4
Sieper, J.5
Wassenberg, S.6
|